Align Technology, Inc. income statement ALGN

In fiscal 2025, which ended Dec 31, 2025, Align Technology, Inc. reported revenue of $4.0 billion, up 0.9% from the year before. Net income was $410.4 million, a profit margin of 10.2%. Operating income came to $545.8 million, an operating margin of 13.5%. Diluted earnings per share were $5.65. Over the twelve months ended Sep 30, 2026, revenue was $4.2 billion and net income was $491.9 million. Across the 10 fiscal years shown, revenue grew from $1.1 billion in fiscal 2016 to $4.0 billion in fiscal 2025, about 15.8% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line
FY 2026
Sep 30, 2026
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
FY 2019
Dec 31, 2019
FY 2018
Dec 31, 2018
FY 2017
Dec 31, 2017
FY 2016
Dec 31, 2016
Revenue
4,159
+4.4%
4,035
+0.9%
3,999
+3.5%
3,862
+3.4%
3,735
-5.5%
3,953
+59.9%
2,472
+2.7%
2,407
+22.4%
1,966
+33.5%
1,473
+36.4%
1,080
+27.7%
Cost of revenue
1,284
+2.0%
1,324
+10.3%
1,200
+3.8%
1,155
+5.0%
1,101
+8.2%
1,017
+43.5%
709
+6.9%
663
+27.8%
519
+45.5%
356
+34.7%
265
+28.8%
Gross profit
2,875
+5.5%
2,711
-3.1%
2,799
+3.4%
2,707
+2.8%
2,634
-10.3%
2,935
+66.5%
1,763
+1.1%
1,744
+20.4%
1,448
+29.6%
1,117
+37.0%
815
+27.4%
Research and development
378
-1.1%
370
+1.6%
364
+5.0%
347
+13.6%
305
+21.9%
250
+42.8%
175
+11.4%
157
+22.1%
129
+32.1%
98
+28.8%
76
+23.7%
Selling, general and administrative
1,780
+2.4%
1,756
-0.4%
1,763
+3.5%
1,703
+1.7%
1,674
-2.0%
1,709
+42.3%
1,201
+12.0%
1,072
+25.8%
852
+28.0%
666
+35.7%
491
+25.7%
Operating income
620
+16.1%
546
-10.2%
608
-5.6%
643
+0.1%
643
-34.2%
976
+152.2%
387
-28.6%
542
+16.3%
467
+31.9%
354
+42.1%
249
+32.0%
Interest income
19
-2.8%
16
-20.6%
20
+17.2%
17
+221.6%
5
+73.0%
3
-0.7%
3
—
—
—
—
Other income (expense)
4
+187.2%
23
+224.4%
-19
+2.6%
-19
+60.3%
-49
-248.6%
33
+390.1%
-11
—
—
—
—
Pretax income
644
+17.2%
585
-3.9%
609
-5.0%
641
+7.0%
599
-40.8%
1,012
+167.2%
379
-32.6%
563
+20.6%
467
+27.9%
365
+50.4%
243
+30.3%
Income tax
152
-10.9%
175
-6.7%
188
-4.4%
196
-17.4%
237
-1.2%
240
+117.2%
-1,397
-1343.4%
112
+94.6%
58
-55.7%
130
+154.2%
51
+21.7%
Net income
492
+30.0%
410
-2.6%
421
-5.3%
445
+23.1%
362
-53.2%
772
-56.5%
1,776
+301.1%
443
+10.6%
400
+72.9%
231
+22.0%
190
+31.7%
Basic EPS
6.89
+33.3%
5.66
+0.5%
5.63
-3.3%
5.82
+26.0%
4.62
-52.8%
9.78
-56.6%
22.55
+304.8%
5.57
+11.4%
5.00
+73.0%
2.89
+21.4%
2.38
+32.2%
Diluted EPS
6.88
+33.2%
5.65
+0.5%
5.62
-3.3%
5.81
+26.0%
4.61
-52.4%
9.69
-56.8%
22.41
+305.2%
5.53
+12.4%
4.92
+73.9%
2.83
+21.5%
2.33
+31.6%
Weighted average shares, basic
71
-2.5%
73
-3.1%
75
-2.0%
76
-2.3%
78
-0.9%
79
+0.2%
79
-0.8%
79
-0.8%
80
-0.0%
80
+0.3%
80
-0.2%
Weighted average shares, diluted
72
-2.4%
73
-3.2%
75
-2.1%
77
-2.4%
78
-1.6%
80
+0.6%
79
-1.1%
80
-1.5%
81
-0.6%
82
+0.4%
81
-0.0%
Other measures
Depreciation and amortization
238
+37.2%
237
+63.7%
145
+1.8%
142
+13.2%
126
+15.7%
109
+16.2%
94
+18.4%
79
+44.3%
55
+45.0%
38
+57.2%
24
+33.3%
EBITDA
859
+21.2%
783
+4.1%
753
-4.2%
786
+2.3%
768
-29.2%
1,085
+125.7%
481
-22.7%
621
+19.2%
521
+33.2%
391
+43.4%
273
+32.1%
Margins
Gross margin
69.14%
67.19%
70.00%
70.08%
70.52%
74.26%
71.33%
72.46%
73.63%
75.81%
75.50%
Operating margin
14.92%
13.53%
15.19%
16.66%
17.21%
24.70%
15.66%
22.54%
23.73%
24.00%
23.05%
Pretax margin
15.49%
14.51%
15.23%
16.60%
16.04%
25.61%
15.33%
23.38%
23.73%
24.76%
22.46%
Profit margin
11.83%
10.17%
10.54%
11.52%
9.68%
19.53%
71.84%
18.40%
20.35%
15.71%
17.57%
EBITDA margin
20.65%
19.41%
18.82%
20.34%
20.57%
27.45%
19.45%
25.82%
26.51%
26.56%
25.27%
Effective tax rate
23.65%
29.89%
30.81%
30.59%
39.64%
23.75%
-368.64%
19.97%
12.37%
35.68%
21.11%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

Company profile

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as
ALGN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Tempe, AZ
SEC filer status
Large accelerated filer
SEC CIK
1097149

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.